Login / Signup

Characterization of a class II ketol-acid reductoisomerase from Mycobacterium tuberculosis .

Ane ValeraShan WangReuben CarrLaurent TrembleauHai Deng
Published in: RSC advances (2022)
Mycobacterium tuberculosis ketol-acid reductoisomerases have been widely studied due to their metabolic importance towards development of drug-resistant bacteria treatment. We here report the biochemical characterization of a new KARI (MtKARI-II) from a Mycobacterium tuberculosis variant with a similar kinetic profile to class I KARIs. Phylogenetic analysis suggested that MtKARI-II is clustered into a class II KARI superfamily.
Keyphrases
  • mycobacterium tuberculosis
  • drug resistant
  • multidrug resistant
  • pulmonary tuberculosis
  • acinetobacter baumannii
  • replacement therapy
  • smoking cessation